Figure S13. NOXA protein contains a potential LIR motif. The amino acid sequence DGFRRL at the position 29-34 in the NOXA protein represents a potential LIR motif with the core consensus sequence ((W/F/Y) XX (L/I/V)). The acidic amino acid is highlighted in red. (TIFF 829 kb
Figure S10. Synergistic cell death after proteasome inhibition and simultaneous fatty acid inhibitio...
Background: Mantle cell lymphoma (MCL) is an aggressive B-non-Hodgkin lymphoma with generally poor o...
Figure S4. The autophagy inhibitor chloroquine blocks KRA-533-induced autophagy in NSCLC cells. A549...
Figure S11. Combination of proteasome inhibition and simultaneous fatty acid inhibition regulates ma...
Table S1. Sequences targeted by the siRNAs used for gene silencing. (TIFF 883 kb
Figure S5. Inhibition CDK4 activity hardly alters NOXA mRNA levels after proteasome inhibition. MCL ...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
Figure S4. CDK4 inhibition antagonizes cell death of NOXA inducing substances. MCL cell line Jeko-1 ...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
Figure S6. Palbociclib-mediated antagonism on bortezomib-induced cell death is not caused by alterat...
Figure S1. CDK4 inhibition by palbociclib treatment inhibits RB1 phosphorylation. MCL cell lines Jek...
Figure S12. Proteasome inhibitors combined with fatty acid inhibition induce synergistic cell death....
Figure S10. Synergistic cell death after proteasome inhibition and simultaneous fatty acid inhibitio...
Background: Mantle cell lymphoma (MCL) is an aggressive B-non-Hodgkin lymphoma with generally poor o...
Figure S4. The autophagy inhibitor chloroquine blocks KRA-533-induced autophagy in NSCLC cells. A549...
Figure S11. Combination of proteasome inhibition and simultaneous fatty acid inhibition regulates ma...
Table S1. Sequences targeted by the siRNAs used for gene silencing. (TIFF 883 kb
Figure S5. Inhibition CDK4 activity hardly alters NOXA mRNA levels after proteasome inhibition. MCL ...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
Figure S4. CDK4 inhibition antagonizes cell death of NOXA inducing substances. MCL cell line Jeko-1 ...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
Figure S6. Palbociclib-mediated antagonism on bortezomib-induced cell death is not caused by alterat...
Figure S1. CDK4 inhibition by palbociclib treatment inhibits RB1 phosphorylation. MCL cell lines Jek...
Figure S12. Proteasome inhibitors combined with fatty acid inhibition induce synergistic cell death....
Figure S10. Synergistic cell death after proteasome inhibition and simultaneous fatty acid inhibitio...
Background: Mantle cell lymphoma (MCL) is an aggressive B-non-Hodgkin lymphoma with generally poor o...
Figure S4. The autophagy inhibitor chloroquine blocks KRA-533-induced autophagy in NSCLC cells. A549...